Concepedia

Hong D. Chu

HD

Statistics

Publications

5

Citations

112

H-Index

5

Active since

2013

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Hong D. Chu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2013–2016

5

Publications

5

Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists

Jason M. Cox, Hong D. Chu, Mariappan V. Chelliah et al. · ACS Medicinal Chemistry Letters · 2016 · 34 citations · Full text

, , +17

Mineralocorticoid receptor antagonists: Identification of heterocyclic amide replacements in the oxazolidinedione series

Jason M. Cox, Hong D. Chu, Christine Yang et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 26 citations · Full text

, , +14

The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors

Jason M. Cox, Hong D. Chu, Jeffrey T. Kuethe et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 22 citations · Full text

, , +14

Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists

Christine Yang, Hong C. Shen, Zhicai Wu et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 17 citations · Full text

, , +12

Discovery of Benzimidazole Oxazolidinediones as Novel and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists

Christine Yang, Jaume Balsells, Hong D. Chu et al. · ACS Medicinal Chemistry Letters · 2015 · 13 citations · Full text

, , +15

1–5 of 5